Justin K. Lui MD, MS
Assistant Professor, Pulmonary, Allergy, Sleep & Critical Care Medicine
Member, Pulmonary Center
72 E. Concord Street | (617) 358-2800justin.lui@bmc.org
Sections
Pulmonary, Allergy, Sleep & Critical Care Medicine
Biography
Dr. Lui is a Pulmonary and Critical Care physician and an Assistant Professor of Medicine at Boston University Chobanian & Avedisian School of Medicine. Dr. Lui's clinical and research interest is in pulmonary hypertension, specifically in systemic sclerosis. Within the Pulmonary Center, he conducts clinical and translational research that is at the intersection of medicine and engineering in applying advanced data science approaches for a deep cardiopulmonary phenotyping of this rare disease population to further advance novel diagnostic and therapeutic approaches.
In addition to his research interests, Dr. Lui is passionate about teaching clinical reasoning, trainee career development, and interprofessional education.
Education
MD, Boston University School of Medicine
MS, Boston University School of Public Health
Publications
Rodriguez JV, Zhang H, Mesfin N, Klings ES, Lui JK. Contribution of QRS Prolongation to Transplant-Free Survival in Sarcoidosis-Related Pulmonary Hypertension. Pulm Circ. 2025 Jan; 15(1):e70021. PMID: 40071062.
Published on 3/10/2025Wong DH, Lui JK. Coaching, Too, Should Count Toward Academic Promotion and Career Advancement. Acad Med. 2025 Mar 10. PMID: 40068003.
Published on 2/1/2025Lui JK, Russo JV, Garcia SI, Kelm DJ, Hinkle LJ. Implementation of Multisource Feedback in Graduate Medical Education. Clin Teach. 2025 Feb; 22(1):e70023. PMID: 39809445.
Published on 12/13/2024Yeo A, Lui JK. The Need to Emphasize Inhaler Education in Residency and Fellowship Training in the Era of Climate Change. J Grad Med Educ. 2024 Dec; 16(6 Suppl):19-21. PMID: 39677908.
Published on 12/9/2024Lui JK, Cozzolino M, Winburn M, Trojanowski MA, Soylemez Wiener R, LaValley MP, Bujor AM, Gopal DM, Klings ES. Clustering regional patterns of left ventricular longitudinal strain in systemic sclerosis-related pulmonary hypertension. Int J Cardiol. 2025 Feb 15; 421:132891. PMID: 39662748.
Published on 6/1/2024Lui JK, Sangani RA, Gillmeyer KR, Vakhshoorzadeh J, Trojanowski MA, Bujor AM, Gopal DM, Wiener RS, LaValley MP, Klings ES. Correction to: Hemodynamic Response to Oral Vasodilator Therapy in Systemic Sclerosis-Related Pulmonary Hypertension. Cardiovasc Drugs Ther. 2024 Jun; 38(3):657. PMID: 36662449.
Published on 12/19/2023Lui JK, Cozzolino M, Winburn M, Trojanowski MA, Wiener RS, LaValley MP, Bujor AM, Gopal DM, Klings ES. Role of Left Ventricular Dysfunction in Systemic Sclerosis-Related Pulmonary Hypertension. Chest. 2024 Jun; 165(6):1505-1517. PMID: 38128607.
Published on 11/13/2023Lui JK, Gillmeyer KR, Sangani RA, Smyth RJ, Gopal DM, Trojanowski MA, Bujor AM, Soylemez Wiener R, LaValley MP, Klings ES. A Clinical Decision Tool for Risk Stratifying Patients with Systemic Sclerosis-Related Pulmonary Hypertension. Lung. 2023 Dec; 201(6):565-569. PMID: 37957388.
Published on 6/17/2023Vakhshoorzadeh J, Lui JK, Sangani RA, Trojanowski MA, Bujor AM, LaValley MP, Klings ES. Emphysema and interstitial lung disease in systemic sclerosis-related pulmonary hypertension. Respir Med. 2023 Sep; 216:107333. PMID: 37336329.
Published on 5/8/2023Wong DH, Lui JK. Telehealth and virtual learning. Clin Teach. 2023 Aug; 20(4):e13581. PMID: 37157137.
Media Mentions
Published on 6/9/2022
Random Forest Model Helps Predict Pulmonary Hypertension for Systemic Sclerosis Patients
View full list of 1 media mentions.